Intervet competitors

Clint Lewis has over 30 years of experience in the life sciences, pharmaceutical and agriculture sectors having previously held senior executive positions across both human health and animal health at Pfizer and Zoetis. He has worked and resided both in the U.S. and in Europe with extensive international travel. At Zoetis, Inc. (NYSE: ZTS), the largest animal health company in the world, Clint played a key role in the successful ‘spin out’ and IPO of the company out of Pfizer in 2013, helping to create over $40B in value creation. Clint served as a corporate officer and member of the Executive Management Team, responsible for setting the over-arching strategy and capital allocation plan for the company. Clint was responsible for leading the global commercial restructuring, a major component of the company’s value creation initiative.As Executive Vice President and Group President, International Operations and Commercial Development for Zoetis, Clint was responsible for all markets outside of the United States, leading a $3.0 billion business comprising a portfolio of products and services across pharmaceuticals, vaccines, medicinal feed additives and diagnostics (serving the veterinary, livestock farmer and agribusiness sectors) with operations in 45 countries and a workforce of over 3,500 people. Under Clint’s leadership international revenues grew by over $600M and operating margins grew by ten percentage points. Additionally, Clint had responsibility for the organization’s life-cycle planning unit which set the strategy and development plans for the top global product franchises which make up approximately 70% of global revenues.Previously, Clint served as the Executive Vice President and President of U.S. Operations at Zoetis. In this role, Clint had responsibility for a $2.5 billion business and a workforce of over 1,200. Under Clint’s leadership, US grew revenues by $1.3 billion and operating margins grew by 15 percentage points.Prior to the formation of Zoetis, Clint spent 25 years in senior commercial and general management roles of increasing responsibility at Pfizer, Inc. across both human and animal health.Clint currently serves a member of the Board of Directors for International Paper (NYSE: IP) and Covis Pharma (a PE backed specialty pharmaceutical company).